Atlas Trials

Lansoprazole Intravenous 30 mg Specified Drug-use Survey [Hemostatic Effect/Rebleeding Rate]

Clinical trial NCT02151786 · COMPLETED

Trial details

NCT number
NCT02151786
Sponsor
Takeda
Status
COMPLETED
Study type
OBSERVATIONAL
Gastric Ulcer, Duodenal Ulcer, Acute Stress Gastritis, and Acute Gastric Mucosal Lesions
Start date
2007-01-01
Primary completion
2010-03-01
Enrollment
1120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.